Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.

Alopecia areata is a hair loss disease caused by complex immune reactions, and new targeted treatments show promise.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

AB+ blood group is more common in alopecia areata patients.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

A woman lost all her hair after mild COVID-19, but it started to regrow after treatment with a specific medication.

Latanoprost 0.005% solution safely increases hair density and regrowth in scalp alopecia areata.

Patients with alopecia areata may have lower vitamin D levels than healthy people.

Dupilumab helped a woman with severe hair loss regrow her hair quickly and maintain it for six months after stopping treatment.

Higher CRBP1 levels are linked to more severe alopecia areata.

Low vitamin D might be one of several factors involved in the hair loss condition alopecia areata.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Using minoxidil and tofacitinib together can effectively treat severe hair loss.

Microneedling with PRP is a safe and effective way to treat chronic alopecia areata, improving hair regrowth with minimal side effects.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

The combination of vitamin D analogues with potent steroids is a favorable treatment for alopecia areata with fewer side effects.

Baricitinib, a medication taken by mouth, was effective in regrowing hair for people with severe hair loss.

Cryotherapy and steroid injections are similarly effective and safe for treating alopecia areata.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

Using Calcipotriol with Clobetasol is more effective for treating Alopecia Areata than using Clobetasol alone.

Combining oral minoxidil with JAK inhibitors helps regrow hair in severe alopecia areata cases.

Kids with alopecia areata had lower vitamin D levels than healthy kids.

New scaffold materials help heal severe skin wounds and improve skin regeneration.

Children with autoimmune hair loss have similar vitamin D levels to healthy kids, suggesting no extra screening is needed.